Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
No shortage on file

OGIVRI

BIOSIMILAR COLLABORATIONS IRELAND LIMITED

Quick answers

Is there a shortage of OGIVRI in Canada?

No. There is no current shortage of OGIVRI 150MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy
StatusNo shortage on file
Same-ingredient products on file6 products

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

ADHEROZA

ACCORD HEALTHCARE INC

150MG · DIN 02550970

Same strengthSame dosage formSame routeNo current shortage

KANJINTI

AMGEN CANADA INC

150MG · DIN 02518244

Same strengthSame dosage formSame routeNo current shortage

Other Products

KADCYLA

HOFFMANN-LA ROCHE LIMITED

100MG · DIN 02412365

Different strengthSame dosage formSame routeNo current shortage

HERCEPTIN

HOFFMANN-LA ROCHE LIMITED

440MG · DIN 02240692

Different strengthSame dosage formSame routeNo current shortage

ENHERTU

ASTRAZENECA CANADA INC

100MG · DIN 02514400

Different strengthSame dosage formSame routeNo current shortage

ONTRUZANT

SAMSUNG BIOEPIS CO., LTD

440MG · DIN 02524325

Different strengthSame dosage formSame routeNo current shortage

DIN

02474425

Strength

150MG

Dosage Form

Powder For Solution

Route

Intravenous

Active Ingredient

TRASTUZUMAB

See all TRASTUZUMAB products →

Shortage History

No shortage or discontinuation reports on file for this product.

Other Products from BIOSIMILAR COLLABORATIONS IRELAND LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.